CARNITOR SF Rx
Generic Name and Formulations:
Levocarnitine 1g/10mL; oral solution; cherry flavor; sugar-free.
Sigma-Tau Pharmaceuticals, Inc.
Indications for CARNITOR SF:
Primary systemic or secondary carnitine deficiency.
Consume slowly in divided doses, preferably with meals; may mix in liquids. Initially 1g/day; titrate slowly; range 1–3g/day.
Consume slowly in divided doses, preferably with meals; may mix in liquids. Initially 50mg/kg per day; titrate slowly; range 50–100mg/kg (max 3g) per day.
Obtain baseline carnitine level; monitor blood chemistry, carnitine levels, vital signs, clinical condition. Seizure disorders. Renal insufficiency (oral forms). Pregnancy (Cat.B). Nursing mothers: not recommended.
Concomitant warfarin: monitor INR.
GI upset/pain, body odor, seizures; inj: hypercalcemia, local reactions.
Tabs—90; Oral soln—4oz; Inj amps or vials (single-dose 5mL)—5
Neurology Advisor Articles
- Clarifying Cardiovascular Risk in Migraine
- More Evidence Supports Benefits of Cannabidiol for Treatment-Resistant Epilepsy
- Parkinson Disease Symptom Fluctuations Well-Managed With Adaptive Deep Brain Stimulation
- Monthly Erenumab Reduces Frequency of Episodic Migraine
- Female Gender, Natalizumab Exposure Associated With Increased Lymphopenia Risk in FNG-Treated MS
- Tamsulosin Associated With Dementia Risk in Older Patients With BPH
- Gait Difficulty in Parkinson Disease May Be Associated With More Progressive Disease Course
- Tau PET a Useful Biomarker for Alzheimer Disease Risk and Progression
- Multiple Sclerosis Drug Zinbryta Withdrawn From the Market
- Predicting Seizure Risk Following Ischemic Stroke With SeLECT Score
- Surgical Outcomes Associated With Trigger Site Deactivation for Migraines
- Combined Exercise Training Increases BDNF in Relapsing-Remitting MS
- Exome-Targeted Capture Sequencing Can Diagnose Previously-Undetected Ataxia
- Strategies for Preventing and Treating Delirium
- High Total Cholesterol Neuroprotective Against Cognitive Decline